Multiple Sclerosis DMT Waste Is STARTLING, New Study Shows (View the photo with the waste build-up)
June 22, 2022 — by: Alicia Bigica More than $5.2 million in new, unused DMTs were collected from patients with…
Beer Consumption May Be Linked to MS Risk: Meta-analysis
Alcohol intake is not significantly associated with an increased risk of developing multiple sclerosis (MS), but specifically drinking beer may elevate…
Stuart Schlossman
Research Opportunity for Individuals Diagnosed with Relapsing-Remitting Multiple Sclerosis! – A study to evaluate the effects of three diets
June 2022 Wahls UIHC Clinical Research is recruiting for a new study! You are invited to participate in a research study…
Stuart Schlossman
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers – PubMed
Monica Margoni 1 2, Paolo Preziosa 1 3, Paola Tortorella 4, Massimo Filippi 1 3 5 6 7, Maria A Rocca 8 9 10 Affiliations expand PMID: 35668317 DOI: 10.1007/s13311-022-01252-5 Abstract Multiple sclerosis (MS) is a chronic inflammatory, demyelinating,…
Stuart Schlossman
Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis
Published by: Science Advances – April 27, 2022 Abstract Multiple sclerosis (MS) is an inflammatory disease of the central nervous…
Stuart Schlossman
Prevalence of MS Among Black People ‘Under-recognized’: Study
by Lindsey Shapiro PhD | May 5, 2022 Rates of multiple sclerosis (MS) were similar among Black and white people, but significantly lower…
Stuart Schlossman
Four new autoantigens trigger multiple sclerosis
Swiss and Swedish researchers have uncovered four previously unknown autoantigens that trigger multiple sclerosis in mice. April 27, 2022 Article…
Stuart Schlossman
MS Living Well Podcast: Multiple Sclerosis Biomarkers including Blood Tests – an interview led by Barry Singer, MD
April 26, 2022 Photo: Rawpixel Rapid recent advancements have led to blood tests (biomarkers) to track multiple sclerosis disease activity.…
Stuart Schlossman
8 More SPMS Patients Cleared for Foralumab Nasal Spray Treatment
by Marta Figueiredo PhD | April 12, 2022 BREAKING NEWS Based on findings from the first two secondary progressive multiple sclerosis (SPMS)…
Stuart Schlossman
Update on Multiple Sclerosis Molecular Biomarkers to Monitor Treatment Effects
ABSTRACT Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous system characterized by broad inter-…
Stuart Schlossman
